Stalk us here
Powered by Fresh Ideas

Kirin Expands Its Biotic Beverage Market Across Asia

Japan 19.08.2026
Source: www.foodnavigator.com
EN 中文 DE FR عربى
Kirin has broadened its biotic beverage market with the iMUSE brand, focusing on postbiotics. In 2026, Kirin relaunched iMUSE in Vietnam and entered new markets such as Taiwan and Singapore.
Kirin Expands Its Biotic Beverage Market Across Asia

Kirin has expanded its reach in the Asian functional beverage market with its iMUSE brand, which focuses on postbiotics. The brand, officially certified in Japan in 2020 for its immune-care benefits, has seen significant growth across Asia. In 2026, Kirin began enhancing its presence in Vietnam and breaking into new markets such as Taiwan and Singapore.

Expansion in Vietnam

iMUSE made its initial foray outside Japan by entering the Vietnamese market back in 2019. Since then, it has witnessed rapid growth. By 2026, the number of stores offering iMUSE in Vietnam increased twentyfold. This expansion led to a nationwide relaunch campaign in June 2026 aimed at sharpening the brand's message and recognition.

Introduction in Taiwan and Singapore

Building on its success in Vietnam, Kirin introduced the iMUSE Lactococcus Lemon Water in Taiwan in June 2026. The launch leveraged the existing popularity of Kirin’s bottled teas, which have experienced substantial growth in the Taiwanese market. Kirin aims to distribute these beverages through various channels, including convenience stores, supermarkets, and online platforms.

The Singaporean launch followed in July 2026 with the introduction of the KIRIN IMMUSE Yoghurt Flavour. This move was in partnership with Fullerton Health to target the health-conscious consumer base in Singapore. The product, assigned a Grade B under the Nutri-Grade system, is part of Kirin’s strategy to cater to the increasing demand for health-focused beverages.

Tailored Approaches

Kirin’s approach to each market has been tailored based on local consumer preferences. In Vietnam, iMUSE products are sold in 430ml bottles, while in Taiwan, they are available in 500ml bottles. The Singapore variant is offered in 200ml bottles, ensuring that every serving delivers 100 billion LC-Plasma.

Toru Yoshimura, Kirin’s President of the Health Science Business Division, stated that the expansion in these markets represents only the first step in a broader strategy to solidify Kirin's international presence, aiming to further localize and innovate its offerings for diverse consumer needs.